Literature DB >> 7100944

Case report 194: primary non-Hodgkin lymphoma of bone.

A K Raymond, K K Unni.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7100944     DOI: 10.1007/BF00349584

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  7 in total

1.  Primary reticulum-cell sarcoma of bone, with emphasis on roentgen aspects.

Authors:  T W WILSON; D G PUGH
Journal:  Radiology       Date:  1955-09       Impact factor: 11.105

2.  Primary reticulum-cell sarcoma of bone; summary of 37 cases.

Authors:  B L COLEY; N L HIGINBOTHAM; H P GROESBECK
Journal:  Radiology       Date:  1950-11       Impact factor: 11.105

3.  The roentgen appearance of primary reticulum cell sarcoma of bone.

Authors:  R S SHERMAN; R E SNYDER
Journal:  Am J Roentgenol Radium Ther       Date:  1947-09

4.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Malignant lymphoma (so-called reticulum cell sarcoma) of bone.

Authors:  H C Boston; D C Dahlin; J C Ivins; R E Cupps
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

6.  Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy.

Authors:  C C Wang; D J Fleischli
Journal:  Cancer       Date:  1968-11       Impact factor: 6.860

7.  Primary histiocytic lymphoma of bone: a light and ultrastructural study of four cases.

Authors:  J P Mahoney; R W Alexander
Journal:  Am J Surg Pathol       Date:  1980-04       Impact factor: 6.394

  7 in total
  2 in total

1.  Case report 487: Primary lymphoma of radius.

Authors:  B M Genez; V L Zirilli; A E Schlesinger; E A Harden; K D Murphy; R F Dryer
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  Case report 730. Malignant large cell lymphoma of tibial epiphysis.

Authors:  M A Giudici; K D Eggli; R P Moser; J S Roloff; E E Frauenhoffer; M J Kransdorf
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.